# Citizens Holding Co: overview CIZN · OTC · CIK 1075706 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cizn.md) · [Financials](/companies/cizn/financials.md) · [Filings](/companies/cizn/filings.md) · [Insiders](/companies/cizn/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.36](/filings/0001437749-23-014421.md) | [0.45](/filings/0001437749-23-023714.md) | [0.46](/filings/0001437749-23-031896.md) | not reported | [0.20](/filings/0001437749-23-014421.md) | [0.05](/filings/0001437749-23-023714.md) | [0.22](/filings/0001437749-23-031896.md) | not reported | | Free cash flow | $k | [2,728](/filings/0001437749-23-014421.md) | [3,571 d](/filings/0001437749-23-023714.md) | [2,354 d](/filings/0001437749-23-031896.md) | [2,465 d](/filings/0001437749-24-009993.md) | [1,131](/filings/0001437749-23-014421.md) | [626 d](/filings/0001437749-23-023714.md) | [1,996 d](/filings/0001437749-23-031896.md) | [1,052 d](/filings/0001437749-24-009993.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.17](/filings/0001193125-22-072539.md) | [1.24](/filings/0001437749-23-006793.md) | [1.34](/filings/0001437749-24-009993.md) | [1.72](/filings/0001437749-24-009993.md) | [0.33](/filings/0001437749-24-009993.md) | | Free cash flow | $m | [12.5](/filings/0001193125-22-072539.md) | [12.0](/filings/0001437749-23-006793.md) | [14.9](/filings/0001437749-24-009993.md) | [11.1](/filings/0001437749-24-009993.md) | [4.8](/filings/0001437749-24-009993.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cizn/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) None of the funds in coverage reports a position in its latest 13F. ## Recent filings [All 464 filings](/companies/cizn/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2024-03-29 | 07:03 ET | [10-K](/filings/0001437749-24-009993.md) | Annual report, period 2023-12-31 | 0001437749-24-009993 | | 2023-12-07 | 12:34 ET | [8-K/A](/filings/0001437749-23-033792.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-033792 | | 2023-12-05 | 12:56 ET | [8-K](/filings/0001437749-23-033539.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-033539 | | 2023-12-05 | 12:54 ET | [8-K](/filings/0001437749-23-033537.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-033537 | | 2023-11-14 | 09:03 ET | [10-Q](/filings/0001437749-23-031896.md) | Quarterly report, period 2023-09-30 | 0001437749-23-031896 | | 2023-11-01 | 13:37 ET | [8-K](/filings/0001437749-23-029569.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-029569 | | 2023-09-14 | 06:23 ET | [8-K](/filings/0001437749-23-025814.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-025814 | | 2023-08-14 | 12:33 ET | [10-Q](/filings/0001437749-23-023714.md) | Quarterly report, period 2023-06-30 | 0001437749-23-023714 | | 2023-07-31 | 09:38 ET | [8-K](/filings/0001437749-23-021142.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-021142 | | 2023-06-07 | 14:13 ET | [8-K](/filings/0001437749-23-016795.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-016795 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2023](/filings/0001437749-24-009993.md), filed Mar 29, 2024. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1075706 - Tickers: CIZN - Exchange: OTC - SIC code: 6022 State Commercial Banks - State of incorporation: MS - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.